Anticoagulation in haemorrhagic cerebral venous thrombosis with post-partum cardiomyopathy: Case Report

Lothar Matheus Manson Vanende Silalahi, Justinus Agung Putranto

Abstract


Introduction: Cerebral venous thrombosis (CVT) is one type of uncommon stroke. The postpartum period is a risk factor for CVT. Cardiomyopathy increases the risk of CVT because of prothrombotic state. CVT may be accompanied with haemorrhage. We reported a haemorrhage CVT with favourably responded with anticoagulant.

Case Presentation: We reported a 29-year-old Female, with acute onset headache, tingling, and left-sided weakness. She had a history of preeclampsia, postpartum cardiomyopathy, and mitral regurgitation. On non-contrast head CT scan revealed right occipital subdural haemorrhage. During hospitalization, the neurological deficit worsened with new-onset seizures. Non-contrast head MRI MRA revealed occipital subacute hematoma and loss of right cerebral vein topography. The patient was treated with low-dose unfractionated heparin (UFH). After 5 days of anticoagulation, the neurological deficit improved with no bleeding complication.

Discussion: Anticoagulant therapy is still recommended despite haemorrhage features in CVT. The choice of CVT therapy recommendations in cases of pregnancy and puerperium is not different. We use UFH because of the readiness of protamine sulphate as antidote and short-acting feature so that we may control the bleeding complication.

Conclusion: CVT may accompanied with haemorrhage. Anticoagulation remains the first-line treatment in CVT. We suggest clinicians to treat CVT with anticoagulant despite the presence of haemorrhage while considering the benefits and risks of the anticoagulant


Keywords


Cerebral venous thrombosis, anticoagulant, haemorrhage

References


Al-Sulaiman, A. (2019). Clinical aspects, diagnosis and management of cerebral vein and dural sinus thrombosis: A literature review. Saudi Journal of Medicine and Medical Sciences, 7(3), 137.

Bose, G., Graveline, J., Yogendrakumar, V., Fergusson, D., & Dowlatshahi, D. (2019). Direct oral anticoagulants in treatment of cerebral venous thrombosis: A systematic review protocol. In Systematic Reviews (Vol. 8, Issue 1). BioMed Central Ltd.

Fanola, C. L., Norby, F. L., Shah, A. M., Chang, P. P., Lutsey, P. L., Rosamond, W. D., Cushman, M., & Folsom, A. R. (2020). Incident Heart Failure and Long-Term Risk for Venous Thromboembolism. Journal of the American College of Cardiology, 75(2), 148–158.

Ferro, J. M., Bousser, M.-G., Canh~ Ao, P., Coutinho, J. M., Crassard, I., Dentali, F., Di Minno, M., Maino, A., Martinelli, I., Masuhr, F., Aguiar De Sousa, D., & Stam, J. (2017). European Stroke Organization guideline for the diagnosis and treatment of cerebral venous thrombosis-endorsed by the European Academy of Neurology. European Journal of Neurology, 24, 1203–1213.

Field, T. S., & Hill, M. D. (2019). Cerebral Venous Thrombosis: We Should Ask the Right Questions to Get Better Answers. In Stroke (Vol. 50, Issue 6, pp. 1598–1604). Lippincott Williams and Wilkins.

Ghandehari, K., Riasi, H. R., Noureddine, A., Masoudinezhad, S., Yazdani, S., Mirzae, M. M., Razavi, A. S., & Ghandehari, K. (2013). Safety assessment of anticoagulation therapy in patients with hemorrhagic cerebral venous thrombosis. In Ir J neurol (Vol. 12, Issue 3). http://ijnl.tums.ac.ir

Gordon, D. L. (2004). The diagnosis and management of cerebral venous thrombosis. In Handbook of Cerebrovascular Diseases, Second Edition, Revised and Expanded (pp. 605–635). CRC Press.

Hegazi, M. O., Ahmed, S., Sakr, M. G., & Hassanien, O. A. (2009). Anticoagulation for cerebral venous thrombosis with subarachnoid hemorrhage: A case report. Medical Principles and Practice, 19(1), 73–75.

Idiculla, P. S., Gurala, D., Palanisamy, M., Vijayakumar, R., Dhandapani, S., & Nagarajan, E. (2020a). Cerebral Venous Thrombosis: A Comprehensive Review. In European Neurology (Vol. 83, Issue 4, pp. 369–379). S. Karger AG.

Misra, U. K., Kalita, J., Chandra, S., Kumar, B., & Bansal, V. (2012). Low molecular weight heparin versus unfractionated heparin in cerebral venous sinus thrombosis: A randomized controlled trial. European Journal of Neurology, 19(7), 1030–1036.

Pongmoragot, J., & Saposnik, G. (2012). Intracerebral hemorrhage from cerebral venous thrombosis. Current Atherosclerosis Reports, 14(4), 382–389.

Shrestha, G. S., Poudyal, B. S., Sedain, G., Mahmud, K. I., & Acharya, N. (2016). Cerebral venous thrombosis presenting with intracerebral hemorrhage in a patient with paroxysmal nocturnal hemoglobinuria. Indian Journal of Critical Care Medicine, 20(2), 117–119.

Shu, L., Bakradze, E., Omran, S. S., Giles, J., Amar, J., Henninger, N., Elnazeir, M., Liberman, A., Moncrieffe, K., Rotblat, J., Sharma, R., Cheng, Y., Zubair, A. S., Simpkins, A., Li, G., Kung, J., Perez, D., Heldner, M. R., Scutelnic, A., … Yaghi, S. (2022). Predictors of Recurrent Venous Thrombosis after Cerebral Venous Thrombosis: Analysis of the

Ulivi, L., Squitieri, M., Cohen, H., Cowley, P., & Werring, D. J. (2020). Cerebral venous thrombosis: A practical guide. In Practical Neurology (Vol. 20, Issue 5, pp. 356–367). BMJ Publishing Group.


Full Text: PDF

DOI: 10.24815/jks.v24i1.33791

Refbacks

  • There are currently no refbacks.